This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) dropped 0.77% to $642.75 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.39% to 4,700.90 and the Dow Jones Industrial Average rising 0.15% to 36,142.22. The stock's fall snapped a four-day winning streak. Regeneron Pharmaceuticals Inc. closed $43.87 short of its 52-week high ($686.62), which the company achieved on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.52% to $162.67, Novartis AG ADR (NOVN.EB) fell 0.45% to $81.91, and Amgen Inc. (AMGN) fell 0.97% to $205.39. Trading volume (625,386) remained 152,142 below its 50-day average volume of 777,528.
Data source: Dow Jones Market Data, FactSet. Data compiled November 16, 2021.
(END) Dow Jones Newswires
November 16, 2021 17:19 ET (22:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.